STAT3 and cancer: Therefore, it is possible that the decline of epidermal EGFR-mediated STAT3 signaling switches the balance in favor of STAT1 activation as it is described for STAT3 knockout conditions in various model systems including cancer cells (Concha-Benavente et al, 2013).